Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $527.73M.
ENTERPRISE VALUE (EV)
$527.73M
Annexon, Inc.
Market Cap
$689.78M
Enterprise Value (EV)
$527.73M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Annexon, Inc. (ANNX) | $689.78M | $527.73M |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | $672.29M |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | $644.25M |
| Helus Pharma Inc. (HELP)vs › | $707.86M | $541.69M |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.33M | $1.44B |
| Achieve Life Sciences, Inc. (ACHV)vs › | $719.64M | $686.63M |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | $592.13M |
| AngioDynamics, Inc. (ANGO)vs › | $642.31M | $588.44M |
| Anteris Technologies Global Corp. (AVR)vs › | $734.10M | $480.04M |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.59M | $620.71M |
Market Cap
$689.78M
Total Debt
$0.00
Cash
$162.05M
Enterprise Value
$527.73M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
